Description

Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human

Although the majority of late-onset Alzheimer's disease (AD) patients are labeled sporadic, multiple genetic risk variants have been identified, the most powerful and prevalent of which is the e4 variant of the Apolipoprotein E (APOE) gene. Here, we generated human induced pluripotent stem cell (hiPSC) lines from the peripheral blood mononuclear cells (PBMCs) of a clinically diagnosed AD patient [ASUi003-A] and a non-demented control (NDC) patient [ASUi004-A] homozygous for the APOE4 risk allele. These hiPSCs maintained their original genotype, expressed pluripotency markers, exhibited a normal karyotype, and retained the ability to differentiate into cells representative of the three germ layers.

Reuse Permissions
  • Downloads
    PDF (633.9 KB)

    Details

    Title
    • Generation and Characterization of Human Induced Pluripotent Stem Cell (hiPSC) Lines From an Alzheimer's Disease (ASUi003-A) and Non-Demented Control (ASUi004-A) Patient Homozygous for the Apolipoprotein e4 (APOE4) Risk Variant
    Contributors
    Date Created
    2017-07-10
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1016/j.scr.2017.07.003
    • Identifier Type
      International standard serial number
      Identifier Value
      1873-5061
    • Identifier Type
      International standard serial number
      Identifier Value
      1876-7753

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Brookhouser, N., Zhang, P., Caselli, R., Kim, J. J., & Brafman, D. A. (2017). Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimers disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant. Stem Cell Research, 25, 266-269. doi:10.1016/j.scr.2017.07.003

    Machine-readable links